JP2008189679A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008189679A5 JP2008189679A5 JP2008066772A JP2008066772A JP2008189679A5 JP 2008189679 A5 JP2008189679 A5 JP 2008189679A5 JP 2008066772 A JP2008066772 A JP 2008066772A JP 2008066772 A JP2008066772 A JP 2008066772A JP 2008189679 A5 JP2008189679 A5 JP 2008189679A5
- Authority
- JP
- Japan
- Prior art keywords
- mitiglinide
- hydrate
- acceptable salt
- pharmacologically acceptable
- voglibose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960003365 mitiglinide Drugs 0.000 claims 14
- WPGGHFDDFPHPOB-BBWFWOEESA-N mitiglinide Chemical compound C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)O)C1=CC=CC=C1 WPGGHFDDFPHPOB-BBWFWOEESA-N 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 claims 12
- 229960001729 voglibose Drugs 0.000 claims 12
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 5
- 239000008103 glucose Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- QEVLNUAVAONTEW-UZYHXJQGSA-L calcium;(2s)-4-[(3as,7ar)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate;dihydrate Chemical compound O.O.[Ca+2].C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1.C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1 QEVLNUAVAONTEW-UZYHXJQGSA-L 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000013329 compounding Methods 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 230000000291 postprandial effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008066772A JP5117230B2 (ja) | 2005-04-20 | 2008-03-14 | ２型糖尿病治療用の併用医薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005121862 | 2005-04-20 | ||
| JP2005121862 | 2005-04-20 | ||
| JP2005166314 | 2005-06-07 | ||
| JP2005166314 | 2005-06-07 | ||
| JP2008066772A JP5117230B2 (ja) | 2005-04-20 | 2008-03-14 | ２型糖尿病治療用の併用医薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007514602A Division JP4230524B2 (ja) | 2005-04-20 | 2006-04-18 | ２型糖尿病治療用の併用医薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000738A Division JP2012092140A (ja) | 2005-04-20 | 2012-01-05 | ２型糖尿病治療用の併用医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008189679A JP2008189679A (ja) | 2008-08-21 |
| JP2008189679A5 true JP2008189679A5 (OSRAM) | 2012-03-15 |
| JP5117230B2 JP5117230B2 (ja) | 2013-01-16 |
Family
ID=37214736
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007514602A Active JP4230524B2 (ja) | 2005-04-20 | 2006-04-18 | ２型糖尿病治療用の併用医薬 |
| JP2008066772A Active JP5117230B2 (ja) | 2005-04-20 | 2008-03-14 | ２型糖尿病治療用の併用医薬 |
| JP2012000738A Pending JP2012092140A (ja) | 2005-04-20 | 2012-01-05 | ２型糖尿病治療用の併用医薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007514602A Active JP4230524B2 (ja) | 2005-04-20 | 2006-04-18 | ２型糖尿病治療用の併用医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000738A Pending JP2012092140A (ja) | 2005-04-20 | 2012-01-05 | ２型糖尿病治療用の併用医薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7888382B2 (OSRAM) |
| EP (1) | EP1872781A4 (OSRAM) |
| JP (3) | JP4230524B2 (OSRAM) |
| KR (1) | KR101380813B1 (OSRAM) |
| CN (1) | CN101198326B (OSRAM) |
| CA (1) | CA2605302A1 (OSRAM) |
| WO (1) | WO2006115115A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101380813B1 (ko) * | 2005-04-20 | 2014-04-04 | 깃세이 야쿠힌 고교 가부시키가이샤 | 2형 당뇨병 치료용 병용 의약 |
| CN105296620B (zh) | 2015-10-26 | 2019-01-15 | 上海市内分泌代谢病研究所 | 肠道宏基因组特征作为2型糖尿病阿卡波糖疗效筛选标志 |
| JP7680822B2 (ja) * | 2017-08-08 | 2025-05-21 | 日本ケミファ株式会社 | 糖尿病治療剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001234114A1 (en) | 2000-02-24 | 2001-09-03 | Takeda Chemical Industries Ltd. | Drugs containing combined active ingredients |
| JP4917712B2 (ja) * | 2000-02-24 | 2012-04-18 | 武田薬品工業株式会社 | 併用医薬 |
| US6830759B2 (en) * | 2002-06-28 | 2004-12-14 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
| CA2490250A1 (en) | 2002-06-28 | 2004-01-08 | Kissei Pharmaceutical Co., Ltd. | Drug composition for blood sugar control |
| WO2004082621A2 (en) * | 2003-03-15 | 2004-09-30 | Bethesda Pharmaceuticals, Inc. | Novel ppar agonists, pharmaceutical compositions and uses thereof |
| TW200521131A (en) * | 2003-08-01 | 2005-07-01 | Janssen Pharmaceutica Nv | Substituted fused heterocyclic c-glycosides |
| WO2005082414A2 (en) * | 2004-03-02 | 2005-09-09 | Astellas Pharma Inc. | Concomitant drugs of a sulfonamide and another therapeutic agent |
| KR101380813B1 (ko) * | 2005-04-20 | 2014-04-04 | 깃세이 야쿠힌 고교 가부시키가이샤 | 2형 당뇨병 치료용 병용 의약 |
| CN101325959A (zh) * | 2005-09-14 | 2008-12-17 | 伊利舍医药品公司 | 用于受控碳水化合物消化的联合疗法 |
-
2006
- 2006-04-18 KR KR1020077025214A patent/KR101380813B1/ko not_active Expired - Fee Related
- 2006-04-18 US US11/918,654 patent/US7888382B2/en not_active Expired - Fee Related
- 2006-04-18 CN CN2006800218679A patent/CN101198326B/zh not_active Expired - Fee Related
- 2006-04-18 EP EP06732039A patent/EP1872781A4/en not_active Withdrawn
- 2006-04-18 JP JP2007514602A patent/JP4230524B2/ja active Active
- 2006-04-18 WO PCT/JP2006/308110 patent/WO2006115115A1/ja not_active Ceased
- 2006-04-18 CA CA002605302A patent/CA2605302A1/en not_active Abandoned
-
2008
- 2008-03-14 JP JP2008066772A patent/JP5117230B2/ja active Active
-
2012
- 2012-01-05 JP JP2012000738A patent/JP2012092140A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3716979T3 (fi) | 4-pyrimidiinisulfamidijohdannaisen ja SGLT-2-inhibiittorin yhdistelmä endoteliiniin liittyvien sairauksien hoitamiseksi | |
| JP2006348039A5 (OSRAM) | ||
| WO2006105501A3 (en) | Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin | |
| JP2010529118A5 (OSRAM) | ||
| EA021275B9 (ru) | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания | |
| MX2010004450A (es) | Derivados heterociclo biciclicos y su uso como moduladores de la actividad de gpr119. | |
| NO20084321L (no) | Triazolderivat eller salt derav | |
| JP2010535252A5 (OSRAM) | ||
| BRPI0818687A2 (pt) | composto espiro, o sal deste farmaceuticamente aceitavél ou o solvato deste, composição farmacêutica, medicamento agonista de gpr40, agente promotor da secreção de insulina ou um agente hipoglicêmico, uso do composto espíro, o sal deste farmaceuticamente aceitavél ou o solvato deste, e, métodos para a ativação de gpr40, para promover secreção de insulina ou diminuir o nível de glicose sanguínea, e para tratar ou prevenir uma doença. | |
| JP2011500690A5 (OSRAM) | ||
| Grade et al. | Standard perioperative management in gastrointestinal surgery | |
| JP2019089796A5 (OSRAM) | ||
| WO2012019188A3 (en) | Methods and compositions for the inhibition of fructokinase | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| WO2004062557A3 (de) | Pharmazeutische kombination aus telmisartan und atorvastatinph zur prophylaxe oder therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen krankheiten | |
| JP2008189679A5 (OSRAM) | ||
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| JP2011519873A5 (OSRAM) | ||
| JP2009516719A5 (OSRAM) | ||
| UA100883C2 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона | |
| JP2012520302A5 (OSRAM) | ||
| WO2004062729A8 (de) | Pharmazeutische kombination zur prophylaxe oder therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen krankheiten | |
| JP2013507383A5 (OSRAM) | ||
| Al-Ghamdi | Carvedilol in the treatment of portal hypertension | |
| JP2011500650A5 (OSRAM) |